Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SCOTT AARON KOTZIN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1215915442
CMS profile
281397
Location
CINCINNATI, OH

General Payments · PY2018–2023

$3,337.77

  • Reported across 203 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$432.16

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $432.16 14

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $124.30 1
IDORSIA PHARMACEUTICALS US INC $100.46 1
Novo Nordisk AS $67.57 4
Lilly USA, LLC $51.26 3
Ethicon Inc. $24.48 1
Gynesonics, Inc. $18.24 1
PFIZER INC. $16.25 1
GlaxoSmithKline, LLC. $15.92 1
Acerta Pharma LLC $13.68 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,083.78 81
PY2019 $722.44 48
PY2020 $369.54 20
PY2021 $397.02 22
PY2022 $332.83 18
PY2023 $432.16 14

Payment records · PY2023 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $124.30 08/22/2023 Food and Beverage Undisputed 01/23/2026 1020118339 CMS
AstraZeneca Pharmaceuticals LP $13.68 04/14/2023 Food and Beverage Undisputed 01/23/2026 1016047563 CMS
Ethicon Inc. $24.48 03/30/2023 Food and Beverage Undisputed 01/23/2026 990901935 CMS
GlaxoSmithKline, LLC. $15.92 03/27/2023 Food and Beverage Undisputed 01/23/2026 1003376185 CMS
Gynesonics, Inc. $18.24 08/22/2023 Food and Beverage Undisputed 01/23/2026 1058158161 CMS
IDORSIA PHARMACEUTICALS US INC $100.46 04/13/2023 Food and Beverage Undisputed 01/23/2026 1034304627 CMS
Lilly USA, LLC $20.28 01/31/2023 Food and Beverage Undisputed 01/23/2026 1032164351 CMS
Lilly USA, LLC $15.12 05/04/2023 Food and Beverage Undisputed 01/23/2026 1032342321 CMS
Lilly USA, LLC $15.86 05/20/2023 Food and Beverage Undisputed 01/23/2026 1032298777 CMS
Novo Nordisk Inc $19.03 01/20/2023 Food and Beverage Undisputed 01/23/2026 1001701625 CMS
Novo Nordisk Inc $18.67 02/21/2023 Food and Beverage Undisputed 01/23/2026 1001701617 CMS
Novo Nordisk Inc $13.26 05/10/2023 Food and Beverage Undisputed 01/23/2026 1001701595 CMS
Novo Nordisk Inc $16.61 08/26/2023 Food and Beverage Undisputed 01/23/2026 1001701606 CMS
PFIZER INC. $16.25 03/01/2023 Food and Beverage Undisputed 01/23/2026 1049763231 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.